Den europeiske union - italiensk - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - farmaci usati nel diabete - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 e 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Den europeiske union - engelsk - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drugs used in diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance.- in addition to other medicinal products for the treatment of type 2 diabetes.for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4.4, 4.5 and 5.1.heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction.chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - telmisartan; hidroclorotiazida - comprimido - 40 mg/12,5 mg - telmisartan 40 mg; hidroclorotiazida 12,5 mg - telmisartán y diuréticos

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - telmisartan; hidroclorotiazida - comprimido - 80 mg/12,5 mg - telmisartan 80 mg; hidroclorotiazida 12,5 mg - telmisartán y diuréticos

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - telmisartan; hidroclorotiazida - comprimido - 80 mg/25 mg - telmisartan 80 mg; hidroclorotiazida 25 mg - telmisartán y diuréticos

Den europeiske union - estisk - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - diabeetis kasutatavad ravimid - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Den europeiske union - ungarsk - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - cukorbetegségben szedett gyógyszerek - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5. és 5. sz. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - aciclovir - comprimido - 200 mg - aciclovir 200 mg - aciclovir

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - rabeprazol sodico - comprimido gastrorresistente - 20 mg - rabeprazol sodico 20 mg - rabeprazol

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - aciclovir - comprimido - 800 mg - aciclovir 800 mg - aciclovir